New combo treatment aims to help people walk again after brain bleed

NCT ID NCT07471256

Not yet recruiting Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Mar 19, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study tests a new approach for people with a large brain bleed (lobar intracerebral hemorrhage). It combines a computer-guided, minimally invasive surgery to drain the clot with a clot-busting drug called tenecteplase. The goal is to see if this treatment helps more people recover the ability to walk independently within 6 months, compared to standard medical care alone. About 636 adults will take part across multiple hospitals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE SPONTANEOUS LOBAR INTRACEREBRAL HEMORRHAGE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Tiantan Hospital, Beijing, China 100000

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE SPONTANEOUS LOBAR INTRACEREBRAL HEMORRHAGE INTRACEREBRAL HEMORRHAGE LOBAR